You question the judgment to own and buy more in a company the market values only at USD$10 million but already has completed a deal worth USD$24 million plus 6% royalties? This same company who has the drug product Brilacidin with excellent scientific research profile plus good results in 3 different Phase 2 clinical trial plus Fast Track and QIDP designation from USA FDA? The same company who owns about 1/3 of a new laser surgery company who should have USA FDA marketing approval next year? I am super comfortable with my judgment.